Increased preoperative levels of plasma fibrinogen and d dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics-Reference-Cited by-同舟云学术

Increased preoperative levels of plasma fibrinogen and d dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics

Published:2014-10 Issue:7 Volume:32 Page:1031-1040
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Erdem Selcuk^ORCID,Amasyali Akin Soner,Aytac Omer,Onem Kadir,Issever Halim,Sanli Oner

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference44 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Prognostic variables to predict cancer-related death in incidental renal tumours;Bensalah;BJU Int,2008

3. Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10 years after initial treatment;Kyoda;Int J Clin Oncol,2014

4. Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma;Tsimafeyeu;J Exp Clin Cancer Res,2009

5. Tissue factor, thrombin, and cancer;Rickles;Chest,2003

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between CT-based adipose variables, preoperative blood biochemical indicators and pathological T stage of clear cell renal cell carcinoma;Heliyon;2024-01

2. D-Dimers Variability in the Perioperative Period of Breast Cancer Surgery Helps to Predict Cancer Relapse: A Single-Centre Prospective Study;Cancer Control;2023-04

3. Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?;BMC Cancer;2022-10-18

4. The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review;European Journal of Surgical Oncology;2022-01

5. Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib;OncoTargets and Therapy;2021-10